Leonteq Securities AG raised its holdings in shares of Centene Corporation (NYSE:CNC – Free Report) by 32.4% in the first quarter, Holdings Channel.com reports. The firm owned 32,246 shares of the company’s stock after purchasing an additional 7,895 shares during the period. Leonteq Securities AG’s holdings in Centene were worth $1,056,000 as of its most recent SEC filing.
A number of other hedge funds have also recently made changes to their positions in CNC. DV Equities LLC bought a new position in Centene during the 4th quarter valued at approximately $26,000. IFC & Insurance Marketing Inc. bought a new stake in Centene in the fourth quarter worth $28,000. SBI Securities Co. Ltd. grew its stake in shares of Centene by 118.4% in the fourth quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock worth $31,000 after acquiring an additional 406 shares during the last quarter. Bayban purchased a new stake in shares of Centene in the fourth quarter worth $33,000. Finally, MV Capital Management Inc. bought a new position in shares of Centene during the fourth quarter valued at $34,000. 93.63% of the stock is owned by institutional investors.
Centene Stock Down 0.1%
CNC opened at $67.80 on Friday. The firm’s 50 day simple moving average is $59.46 and its two-hundred day simple moving average is $46.95. The company has a market capitalization of $33.48 billion, a PE ratio of -5.16, a PEG ratio of 0.53 and a beta of 1.07. Centene Corporation has a 1-year low of $25.08 and a 1-year high of $69.29. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.76.
Analyst Upgrades and Downgrades
A number of equities analysts recently issued reports on CNC shares. The Goldman Sachs Group reiterated a “sell” rating and issued a $40.00 price target on shares of Centene in a research note on Wednesday, April 29th. Deutsche Bank Aktiengesellschaft upgraded shares of Centene from a “hold” rating to a “buy” rating and raised their price objective for the company from $53.00 to $80.00 in a research note on Wednesday, May 20th. UBS Group reiterated a “neutral” rating and set a $61.00 price target (up from $55.00) on shares of Centene in a report on Friday, May 22nd. Sanford C. Bernstein boosted their price objective on shares of Centene from $48.00 to $68.00 and gave the stock an “outperform” rating in a report on Tuesday, May 5th. Finally, Raymond James Financial set a $60.00 price objective on Centene in a research report on Wednesday, April 29th. Seven analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $60.78.
Get Our Latest Stock Report on Centene
About Centene
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Recommended Stories
- Five stocks we like better than Centene
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
